BIODESIX INC — Director's Dealing 2020

Dec 10, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIODESIX INC (BDSX)
CIK: 0001439725
Period of Report: 2020-12-07

Reporting Person: PATIENCE JOHN (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-12-07	Common Stock	M	35157	$6.83	Acquired	35157	Direct
2020-12-07	Common Stock	M	23440	$6.83	Acquired	58597	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-12-07	Stock Options (Right to Buy)	$6.83	M	35157	Disposed	2029-07-15	Common Stock (35157)	Direct
2020-12-07	Stock Options (Right to Buy)	$6.83	M	23440	Disposed	2030-04-14	Common Stock (23440)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1910968	Indirect
Common Stock	2811431	Indirect
Common Stock	30000	Indirect

Footnotes

F1: The reporting person is the sole general partner of Patience Enterprises LP. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

F2: The reporting person is the sole trustee of John Patience Trust (July 23, 1993).

F3: This option vested in 12 successive, equal monthly installments measured from April 1, 2019.

F4: This option vests in 12 successive, equal monthly installments measured from April 1, 2020.